000 04761nam a22005175i 4500
001 978-94-007-5799-8
003 DE-He213
005 20140220082939.0
007 cr nn 008mamaa
008 130217s2013 ne | s |||| 0|eng d
020 _a9789400757998
_9978-94-007-5799-8
024 7 _a10.1007/978-94-007-5799-8
_2doi
050 4 _aR-RZ
072 7 _aMBGR
_2bicssc
072 7 _aMED000000
_2bisacsh
082 0 4 _a610
_223
100 1 _aRitsner, Michael S.
_eeditor.
245 1 0 _aPolypharmacy in Psychiatry Practice, Volume II
_h[electronic resource] :
_bUse of Polypharmacy in the "Real World" /
_cedited by Michael S. Ritsner.
264 1 _aDordrecht :
_bSpringer Netherlands :
_bImprint: Springer,
_c2013.
300 _aXVII, 321 p. 2 illus., 1 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _a1. Antipsychotic polypharmacy for schizophrenia: 'Secret sauce' or 'wild abandon'? -- Antipsychotic polypharmacy in USA -- Antipsychotic polypharmacy in Czech Republic and in Ukraine -- Antipsychotic polypharmacy in residential facilities in Italy: the gap between recommendations and real world practice -- Antipsychotic polypharmacy and associated phenomena in patients with schizophrenia: Rational or irrational? -- Antipsychotic polypharmacy in schizophrenia. How to counteract this common practice? -- Clozapine combinations in treatment-resistant schizophrenia patients -- Metabolic syndrome and antipsychotic polypharmacy -- Evidence based combination therapy for bipolar disorder -- Antidepressant combination strategies for major depressive disorder -- Herbal remedies and nutraceuticals as augmentation or adjunct for mood and anxiety disorders: evidence for benefit and risk -- Obsessive-compulsive syndromes in schizophrenia: A case for polypharmacy? -- Polypharmacy and potentially inappropriate medication use among elders with dementia -- The role of polypharmacy in bipolar disorder treatment guidelines.
520 _aDespite the large number of psychotropic medications currently available, effective management of mental disorders continues to be a challenging task. Although monotherapy may be desirable, most patients require combinations of two or more psychotropic drugs. Polypharmacy aims to address different aspects of treatment resistance, especially insufficient response of positive and negative symptoms, cognitive disturbances, affective comorbidity, obsessive-compulsive syndromes and side-effects of antipsychotic agents. At the same time, evidence based guidelines in support of polypharmacy, and augmentative strategies are scant. This two-volume collection is the first comprehensive, clinically oriented, reference text on polypharmacy (co-administration of more than one medication) or the use of multiple preparations to treat psychotic, cognitive, mood and anxiety disorders. This collection is divided into four parts. Volume I contains two parts including chapters that serve as an introduction and overview of conceptual issues. Key topics include: rational polypharmacy, receptor binding targets, drug interactions, preclinical and clinical investigations in this field, dosing regimens, multiple medication use in forensic psychiatry, a naturalistic trial, adjunctive strategies, and multiple medication use for the treatment of somatic symptom disorders. Volume II contains two parts that focus on antipsychotic polypharmacy for schizophrenia, and clinical practice in the USA, Czech Republic, Ukraine, and Italy, polypharmacy and associated phenomena, clozapine combinations and the metabolic syndrome. The authors discuss combination therapy for bipolar disorder, major depressive disorder, obsessive-compulsive syndromes in schizophrenia, and potentially inappropriate medication use among elderly patients with dementia. Finally, each volume includes Appendix contains ‘Annotated bibliography on polypharmacy’ and ‘List of Psychotropic Medications’.
650 0 _aMedicine.
650 0 _aPharmacy.
650 0 _aPsychiatry.
650 0 _aPsychopharmacology.
650 0 _aMedical Education.
650 0 _aPsychology, clinical.
650 1 4 _aBiomedicine.
650 2 4 _aBiomedicine general.
650 2 4 _aPsychiatry.
650 2 4 _aPharmacy.
650 2 4 _aClinical Psychology.
650 2 4 _aMedical Education.
650 2 4 _aPsychopharmacology.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789400757981
856 4 0 _uhttp://dx.doi.org/10.1007/978-94-007-5799-8
912 _aZDB-2-SBL
999 _c99719
_d99719